East Setauket, NY, United States of America

Michael H Dosik

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2010.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael H Dosik: Innovator in Cancer Research

Introduction

Michael H Dosik is a notable inventor based in East Setauket, NY (US). He has made significant contributions to the field of cancer research through his innovative work on gene compositions. His expertise and dedication to advancing medical science have led to the development of valuable patents.

Latest Patents

Michael H Dosik holds 1 patent related to ELF3 gene compositions and methods. This patent provides insights into ELF3 gene compositions associated with cancer, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alu. Additionally, the patent outlines methods and kits that utilize primers or probes to detect the presence of these ELF3 gene compositions. It also includes methods for determining whether a cell comprises a virus.

Career Highlights

Throughout his career, Michael has focused on the intersection of genetics and cancer research. His work has contributed to a deeper understanding of the genetic factors involved in cancer, paving the way for potential diagnostic and therapeutic advancements.

Collaborations

Michael has collaborated with esteemed colleagues, including Mark H Kaplan and Xue-Ping Wang. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that encourages innovation.

Conclusion

Michael H Dosik's contributions to cancer research through his innovative patents highlight his commitment to advancing medical science. His work continues to inspire future research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…